Income Statement
SPRUCE BIOSCIENCES, INC.
SPRB
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Revenue
|
0.00 | 4.91 | 10.10 | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - |
|
Gross Profit
|
- | 4.91 | 10.10 | - | - | - |
|
Operating Expenses
|
36.51 | 61.06 | 62.08 | 47.28 | 42.07 | 29.42 |
|
Research & Development
|
19.52 | 46.42 | 49.43 | 35.20 | 30.70 | 23.85 |
|
Selling, General & Administrative
|
16.99 | 14.64 | 12.65 | 12.09 | 11.37 | 5.56 |
|
Other Operating Expenses
|
- | - | - | - | - | - |
|
Operating Income
|
-36.51 | -56.15 | -51.98 | -47.28 | -42.07 | -29.42 |
|
Non-Operating Income
|
- | - | - | - | - | - |
|
Interest Income
|
- | - | - | - | - | - |
|
Interest Expense
|
0.09 | 0.31 | 0.48 | 0.42 | 0.35 | 0.32 |
|
Other Non-Op Income / Expense
|
- | - | - | - | 0.12 | 0.20 |
|
Income Before Tax
|
- | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - |
|
Net Income
|
-38.97 | -53.04 | -47.92 | -46.18 | -42.29 | -29.54 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - |
|
EBITDA
|
-36.49 | -56.11 | -51.91 | -47.21 | -42.00 | -29.38 |
|
Earnings Per Share (Basic)
|
-50.83 | -1.29 | -1.24 | -1.96 | - | - |
|
Diluted EPS
|
-50.83 | -1.29 | -1.24 | -1.96 | - | - |
|
Weighted Average Shares
|
0.77 | 41.26 | 38.51 | 23.53 | - | - |
|
Diluted Weighted Avg Shares
|
0.77 | 41.26 | 38.51 | 23.53 | - | - |
|
Comprehensive Income
|
- | -53.04 | -47.36 | -46.55 | -42.48 | - |